AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.

AT1 RECEPTOR AUTOANTIBODIES MEDIATE EFFECTS OF METABOLIC SYNDROME ON DOPAMINERGIC VULNERABILITY.

Detalhes bibliográficos
Principais autores:	Ana Isabel Rodríguez Pérez, María A Pedrosa, Carmen M Labandeira, Rita Valenzuela, Aloia Quijano, Mariña Sanchez-Andrade, Juan Antonio Suárez-Quintanilla, Jose Lanciego, José Luis Labandeira-García
Formato:	Artigo
Idioma:	English
Publicado em:	Elsevier 2023-10-01
coleção:	IBRO Neuroscience Reports
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2667242123010126

Registros relacionados

ANGIOTENSIN TYPE-1 RECEPTOR AND ACE2 AUTOANTIBODIES IN PARKINSON´S DISEASE
por: Ana Isabel Rodríguez Pérez, et al.
Publicado em: (2023-10-01)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
por: Carmen M. Labandeira, et al.
Publicado em: (2022-06-01)

Angiotensin type-1 receptor autoantibodies promote alpha-synuclein aggregation in dopaminergic neurons
por: Lucia Lage, et al.
Publicado em: (2024-11-01)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
por: Jose L. Labandeira-Garcia, et al.
Publicado em: (2022-02-01)

Brain renin-angiotensin system and dopaminergic cell vulnerability
por: Jose L Labandeira-Garcia, et al.
Publicado em: (2014-07-01)

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria
por: Rita Valenzuela, et al.
Publicado em: (2021-10-01)

Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
por: Maria A. Pedrosa, et al.
Publicado em: (2023-11-01)

Renin angiotensin system and gender differences in dopaminergic degeneration
por: Rodriguez-Perez Ana I, et al.
Publicado em: (2011-08-01)

NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death
por: Andrea Lopez-Lopez, et al.
Publicado em: (2021-08-01)

Angiotensin Type-1 Receptor Inhibition Reduces NLRP3 Inflammasome Upregulation Induced by Aging and Neurodegeneration in the <i>Substantia Nigra</i> of Male Rodents and Primary Mesencephalic Cultures
por: Aloia Quijano, et al.
Publicado em: (2022-02-01)

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR.
por: Juan Parga, et al.
Publicado em: (2023-10-01)

CALBINDIN CONTENT AND DIFFERENTIAL VULNERABILITY OF MIDBRAIN EFFERENT DOPAMINERGIC NEURONS IN MACAQUES
por: Iria G Dopeso-Reyes, et al.
Publicado em: (2014-12-01)

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19
por: Rita Valenzuela, et al.
Publicado em: (2021-04-01)

LOCATION OF LEWY BODIES IS DRIVING DOPAMINERGIC CELL VULNERABILITY IN NON-HUMAN PRIMATES
por: Julia Chocarro, et al.
Publicado em: (2023-10-01)

MESENCHYMAL STROMAL CELLS IMPROVE DOPAMINERGIC GRAFT SURVIVAL AND REINNERVATION IN PARKINSON'S DISEASE ANIMAL MODEL IN A DOSE-DEPENDENT WAY
por: Juan Parga, et al.
Publicado em: (2023-10-01)

Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors
por: Begoña Villar-Cheda, et al.
Publicado em: (2012-08-01)

Ecology and Evolution of Gall-Inducing Arthropods: The Pattern From the Terrestrial Fossil Record
por: Conrad C. Labandeira, et al.
Publicado em: (2021-06-01)

Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease
por: Domingo Afonso-Oramas, et al.
Publicado em: (2009-12-01)

Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models
por: Ana I. Rodríguez-Pérez, et al.
Publicado em: (2024-05-01)

THE ANGIOTENSIN-TYPE-2 RECEPTORS ARE INVOLVED IN AGE-RELATED CHANGES AND NEUROINFLAMMATION IN THE SUBSTANTIA NIGRA
por: Pablo Garrido-Gil, et al.
Publicado em: (2023-10-01)

Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
por: Ana Muñoz, et al.
Publicado em: (2020-06-01)

THE ANGIOTENSIN TYPE 2 RECEPTOR GENE MEDIATES SEXUAL DIMORPHISM IN MICROGLIAL INFLAMMATORY RESPONSES
por: Pablo Garrido-Gil, et al.
Publicado em: (2023-10-01)

The role of the brain renin-angiotensin system in Parkinson´s disease
por: Jose Luis Labandeira-Garcia, et al.
Publicado em: (2024-04-01)

Su Friedrich: Interviews, edited by Sonia Misra and Rox Samer
por: Sibley Labandeira
Publicado em: (2024-07-01)

Labour-Intensive Filmmaking: An Interview with Su Friedrich
por: Sibley Labandeira
Publicado em: (2024-07-01)

The four phases of plant-arthropod associations in deep time
por: C. LABANDEIRA
Publicado em: (2006-01-01)

Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease
por: Ana I. Rodriguez-Perez, et al.
Publicado em: (2013-10-01)

Brain angiotensin enhances dopaminergic cell death via microglial activation and NADPH-derived ROS
por: J. Rodriguez-Pallares, et al.
Publicado em: (2008-07-01)

Calbindin and Girk2/Aldh1a1 define resilient vs vulnerable dopaminergic neurons in a primate Parkinson’s disease model
por: Natalia López-González del Rey, et al.
Publicado em: (2024-09-01)

Escribano Hernández, Julio. «Caballero de Vivar. Mozárabe histórico, fiel guerrero y héroe literario»
por: Amancio Labandeira Fernández
Publicado em: (2023-12-01)

La transparencia y la rendición de cuentas como elementos de innovación en los municipios catalanes:
por: Raúl Labandeira García
Publicado em: (2020-02-01)

Sampling fossil floras for the study of insect herbivory: how many leaves is enough?
por: S. R. Schachat, et al.
Publicado em: (2020-02-01)

Unmasking adenosine 2A receptors (A2ARs) in monkey basal ganglia output neurons using cholera toxin subunit B (CTB)
por: Natasha Luquin, et al.
Publicado em: (2012-09-01)

Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
por: Tomás González-Hernández, et al.
Publicado em: (2010-10-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
por: Javier eBlesa, et al.
Publicado em: (2015-09-01)

Plant interactions with arthropods and pathogens at Sanzenbacher Ranch, early Permian of Texas, and implications for herbivory evolution in Southwestern Euramerica
por: Thamiris Barbosa Dos Santos, et al.
Publicado em: (2024-03-01)

Interactions between Angiotensin Type-1 Antagonists, Statins, and ROCK Inhibitors in a Rat Model of L-DOPA-Induced Dyskinesia
por: Andrea Lopez-Lopez, et al.
Publicado em: (2023-07-01)

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease
por: Garrido-Gil Pablo, et al.
Publicado em: (2012-02-01)

PARKINSON’S DISEASE: ANIMAL MODELS AND DOPAMINERGIC CELL VULNERABILITY
por: Javier eBlesa, et al.
Publicado em: (2014-12-01)

Enfermedad de Paget extramamaria en varón
por: Marta Isabel Méndez Fabeiro, et al.
Publicado em: (2014-12-01)